Metabolomics Workbench : NIH Data Repository

MB Sample ID: SA331299

Local Sample ID:	Donor_6_Plasma_after_Aspirin_2
Subject ID:	SU003165
Subject Type:	Human
Subject Species:	Homo sapiens
Taxonomy ID:	9606
Gender:	Male and female

Select appropriate tab below to view additional metadata details:

All
Subject
Factors
Collection
Treatment
Sample Preparation
Chromatography
Analysis
MS

Treatment:

Treatment ID:	TR003174
Treatment Summary:	Subjects were randomized to receive either acetylsalicylic acid or Omega-3 capsules for 7 days. One study cohort was instructed to take 500 mg acetylsalicylic acid (Aspirin® 500 mg acetylsalicylic acid, Cellulose powder, maize starche) per day in the evening whereas the second study cohort was instructed to take two Omega-3 complex 870 mg capsules (Br. Böhm Omega-3 capsules, 1017 mg cold water fish oil equivalent to 870 mg Omega-3, consisting of 420 mg EPA, 330 mg DHA, 5μg Vitamin D equivalent to 200 IU, 6 mg Vitamin E, 30 mg Co-enzyme Q10) per day in the evening.

Treatment ID:

TR003174

Treatment Summary:

Subjects were randomized to receive either acetylsalicylic acid or Omega-3 capsules for 7 days. One study cohort was instructed to take 500 mg acetylsalicylic acid (Aspirin® 500 mg acetylsalicylic acid, Cellulose powder, maize starche) per day in the evening whereas the second study cohort was instructed to take two Omega-3 complex 870 mg capsules (Br. Böhm Omega-3 capsules, 1017 mg cold water fish oil equivalent to 870 mg Omega-3, consisting of 420 mg EPA, 330 mg DHA, 5μg Vitamin D equivalent to 200 IU, 6 mg Vitamin E, 30 mg Co-enzyme Q10) per day in the evening.